First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19
Crit Care
.
2020 Jun 18;24(1):363.
doi: 10.1186/s13054-020-03070-7.
Authors
Klaus Stahl
1
,
Christian Bode
2
,
Sascha David
3
Affiliations
1
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
2
Department of Anaesthesiology and Critical Care, University Medicine Bonn, Bonn, Germany.
3
Department of Nephrology and Hypertension, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany. david.sascha@mh-hannover.de.
PMID:
32552832
PMCID:
PMC7301767
DOI:
10.1186/s13054-020-03070-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Pandemics
Plasma Exchange
Pneumonia, Viral
SARS-CoV-2